Zydus Lifesciences’ animal health division, ZyVet, has launched the first FDA-approved generic treatment for canine urinary incontinence and an affordable generic version of Furosemide tablets for long-term heart care in dogs and cats. These launches underscore ZyVet’s mission to provide trusted, high-quality, and cost-effective therapies to veterinary professionals.
Expanding Affordable Veterinary Treatments
ZyVet Animal Health, a division of Zydus Lifesciences, has introduced two new generic medications aimed at improving the accessibility and affordability of veterinary treatments. The new offerings include treatments for canine urinary incontinence and long-term heart care for dogs and cats.
First Generic for Canine Urinary Incontinence
ZyVet has launched the first FDA-approved generic of phenylpropanolamine hydrochloride tablets, a trusted treatment for managing urinary incontinence in dogs. This medication addresses urethral sphincter hypotonus, a common issue in spayed females and aging dogs, offering reliable symptom relief and supporting client compliance. The product is available in multiple strengths for precise dosing.
Affordable Furosemide Tablets for Heart Care
The company also introduced affordable Furosemide tablets, a generic version of a trusted diuretic for dogs and cats needing long-term heart care. This medication supports the reduction of edema and pulmonary congestion due to cardiac, renal, or systemic disease. It provides veterinarians a consistent, cost-effective solution without compromising dosing flexibility or product availability.
ZyVet’s Commitment to Affordable Innovation
These launches reinforce ZyVet’s commitment to providing affordable innovation to the veterinary market, ensuring that high-quality treatments are accessible to more pet owners. Punit Patel, President and CEO, Zydus Americas, emphasized that the company is proud to offer options that remove cost as a barrier to compassionate care.
Driving Paradigm Shift in the Industry
ZyVet’s expansion reinforces that generic animal health products are as effective as pioneer brands. ZyVet benefits from more than 70 years of pharmaceutical R&D, Regulatory, QA/QC, manufacturing scale, excellence and expertise.
Source: BSE
